Posts in tag
Calimmune
Calimmune raises $15M in Series B
What does Calimmune do? Calimmune, is a clinical stage gene therapy company. Its lead therapeutic candidate, is a gene based therapy which is engineered to control HIV infection and for protecting individuals with HIV from advancing to AIDS. The therapy is presently being evaluated in Phase I/II studies. Cal- 1 is designed for reducing production …